Taking Control of our Own Healthcare: Defending the maligned and misunderstood PSA test. KMI Learning, a leader in healthcare eLearning, announces the release of the second in a series of patient education videos on prostate cancer. The series is being developed in cooperation with the Prostate Cancer Research Institute of Los Angeles, California and Prostate Oncology Specialists of Marina del Rey, California. The videos are intended to clear up misconceptions surrounding the diagnosis and overtreatment of this cancer which is different for every man, ranging from a very serious, to very slow-growing disease.
One year after our first award-winning Security Awareness training course this Financial Services organization was ready to roll-out a follow-up. The new material would include a partial revision to the original course in addition to a number of new topics. We were challenged with determining how to reconcile the new information with the previous course in an equally effective manner yet under tighter budget restrictions.
* This post is a re-blog from our partners at Prostate Oncology Specialists and the Prostate Cancer Research Institute First Stop on the Overtreatment Express: The Unnecessary Biopsy RALPH BLUM The first four words of the subtitle of our book, Invasion of the Prostate Snatchers are, “No More Unnecessary Biopsies.” At the appropriate time, a biopsy is an essential diagnostic tool. Unfortunately, however, far too many urologists still schedule an immediate biopsy if there is even a slight rise in PSA. And that has led to a multi-billion dollar industry bent on administering treatment to every kind of prostate cancer, whether it is life-threatening or not.